LSP Closes Mega Life Sciences Fund For Europe, But US Still Way Ahead
Family Offices And Pharma Commit Funding
Executive Summary
A new life sciences fund, LSP 6, is one of the largest fundraisings in Europe in the sector, and will invest in around 15-to-18 pharma or medtech companies.
You may also be interested in...
Sofinnova Raises €333m For European Biotech Fund
Global investors back Paris-headquartered Sofinnova to recoup investment in life science start-ups.
Alizé Pharma 3 Raises €67m To Build ‘Fully Fledged’ Biotech
The Series A financing positions Alizé to take a rival to Shire’s Natpara through to clinical proof of concept over the next few years.
Wellington Partners Unveils €210m Eurocentric Biotech/Medtech Fund WPLS-V
With its WPLS-IV fund now fully committed, Wellington Partners has returned to the market and raised €210m in its WPLS-V fund which will focus on European biotech and medtech opportunities.